Efficacy and limitations of additional steroid pulse therapy in IgA nephropathy patients whose hematuria did not remit on tonsillectomy and protocol steroid pulse therapy
© 2022. The Author(s), under exclusive licence to The Japanese Society of Nephrology..
BACKGROUND: Hematuria is the essential symptom of IgA nephropathy that has been suggested to be associated with long-term renal prognosis, Tonsillectomy and steroid pulse therapy (TSP), which is widely practiced in Japan, is effective for achieving hematuria remission. However, some cases are refractory to TSP, and additional steroid pulse therapy (SP) administered to these cases to achieve remission of hematuria. Nonetheless, the clinical significance of additional SP is unknown.
METHODS: In this retrospective study, we enrolled 99 patients from Okubo Hospital whose hematuria persisted following TSP. Patients were divided into the hematuria remission and non-remission groups. A multivariate regression analysis was performed on the factors that contributed to hematuria remission.
RESULTS: Following TSP, 103 of 403 patients (32.3%) did not achieve hematuria remission. Additional SP were performed in 99 of these patients, and remission of hematuria was achieved in 57 (57.6%). Patients with a greater degree of improvement in hematuria with TSP were significantly more likely to have remission of hematuria with additional SP (p = 0.0084*). Even in the hematuria non-remission group, both hematuria and proteinuria improved after additional SP.
CONCLUSION: In IgA nephropathy, additional SP could induce hematuria remission and reduce proteinuria.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Clinical and experimental nephrology - 26(2022), 9 vom: 29. Sept., Seite 859-866 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Toda, Minami [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Additional steroid pulse therapy (additional SP) |
|---|
| Anmerkungen: |
Date Completed 19.08.2022 Date Revised 19.08.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10157-022-02226-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340151617 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340151617 | ||
| 003 | DE-627 | ||
| 005 | 20231226004508.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10157-022-02226-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1133.xml |
| 035 | |a (DE-627)NLM340151617 | ||
| 035 | |a (NLM)35486336 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Toda, Minami |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efficacy and limitations of additional steroid pulse therapy in IgA nephropathy patients whose hematuria did not remit on tonsillectomy and protocol steroid pulse therapy |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.08.2022 | ||
| 500 | |a Date Revised 19.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s), under exclusive licence to The Japanese Society of Nephrology. | ||
| 520 | |a BACKGROUND: Hematuria is the essential symptom of IgA nephropathy that has been suggested to be associated with long-term renal prognosis, Tonsillectomy and steroid pulse therapy (TSP), which is widely practiced in Japan, is effective for achieving hematuria remission. However, some cases are refractory to TSP, and additional steroid pulse therapy (SP) administered to these cases to achieve remission of hematuria. Nonetheless, the clinical significance of additional SP is unknown | ||
| 520 | |a METHODS: In this retrospective study, we enrolled 99 patients from Okubo Hospital whose hematuria persisted following TSP. Patients were divided into the hematuria remission and non-remission groups. A multivariate regression analysis was performed on the factors that contributed to hematuria remission | ||
| 520 | |a RESULTS: Following TSP, 103 of 403 patients (32.3%) did not achieve hematuria remission. Additional SP were performed in 99 of these patients, and remission of hematuria was achieved in 57 (57.6%). Patients with a greater degree of improvement in hematuria with TSP were significantly more likely to have remission of hematuria with additional SP (p = 0.0084*). Even in the hematuria non-remission group, both hematuria and proteinuria improved after additional SP | ||
| 520 | |a CONCLUSION: In IgA nephropathy, additional SP could induce hematuria remission and reduce proteinuria | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Additional steroid pulse therapy (additional SP) | |
| 650 | 4 | |a Hematuria remission | |
| 650 | 4 | |a IgA nephropathy | |
| 650 | 4 | |a Tonsillectomy and steroid pulse therapy (TSP) | |
| 650 | 7 | |a Steroids |2 NLM | |
| 700 | 1 | |a Kume, Aya |e verfasserin |4 aut | |
| 700 | 1 | |a Hara, Masato |e verfasserin |4 aut | |
| 700 | 1 | |a Kimura, Hitomi |e verfasserin |4 aut | |
| 700 | 1 | |a Nakamura, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Okumura, Koichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Beppu, Hiroko |e verfasserin |4 aut | |
| 700 | 1 | |a Nakamura, Yuka |e verfasserin |4 aut | |
| 700 | 1 | |a Ogawa, Hina |e verfasserin |4 aut | |
| 700 | 1 | |a Kamei, Yuiko |e verfasserin |4 aut | |
| 700 | 1 | |a Ishiwatari, Ayumi |e verfasserin |4 aut | |
| 700 | 1 | |a Kawanishi, Tomoko |e verfasserin |4 aut | |
| 700 | 1 | |a Ogawa, Toshie |e verfasserin |4 aut | |
| 700 | 1 | |a Abe, Yasutomo |e verfasserin |4 aut | |
| 700 | 1 | |a Endo, Mariko |e verfasserin |4 aut | |
| 700 | 1 | |a Wakai, Sachiko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and experimental nephrology |d 1998 |g 26(2022), 9 vom: 29. Sept., Seite 859-866 |w (DE-627)NLM096492473 |x 1437-7799 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2022 |g number:9 |g day:29 |g month:09 |g pages:859-866 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10157-022-02226-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2022 |e 9 |b 29 |c 09 |h 859-866 | ||